(Q54389748)

29 May 2018

title

Evaluation of various cytostatic drugs as local immunotherapeutic agents (English)

1 reference

30 September 2023

1 reference

1 reference

30 September 2023

1 reference

30 September 2023

author name string

R. J. Scheper

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6332093

30 September 2023

A. Vos

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6332093

30 September 2023

J. de Groot

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6332093

30 September 2023

G. H. Boerrigter

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6332093

30 September 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6332093

30 September 2023

publication date

1 January 1984

1 reference

29 May 2018

full work available at URL

https://link.springer.com/content/pdf/10.1007/BF00232355.pdf

file format

Portable Document Format

1 reference

https://link.springer.com/article/10.1007/BF00232355/fulltext.html

30 September 2023

1 reference

http://link.springer.com/content/pdf/10.1007/BF00232355

30 September 2023

1 reference

Investigational New Drugs

30 September 2023

published in

1 reference

29 May 2018

volume

2

1 reference

29 May 2018

issue

2

1 reference

29 May 2018

page(s)

221-225

1 reference

29 May 2018

https://scigraph.springernature.com/pub.10.1007/bf00232355

exact match

0 references

cites work

Effect of Cyclophosphamide on Immunological Control Mechanisms

1 reference

12 December 2020

Enhancement of delayed hypersensitivity reaction with varieties of anti-cancer drugs. A common biological phenomenon

1 reference

12 December 2020

Augmentation of the human immune response by cyclophosphamide

1 reference

12 December 2020

Regulation of delayed-type hypersensitivity. III. Effect of cyclophosphamide on the suppressor cells for delayed-type hypersensitivity to sheep erythrocytes in mice

1 reference

12 December 2020

Intratumoral BCG therapy of transplanted head and neck tumors in strain 2 guinea pigs

1 reference

12 December 2020

Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells

1 reference

12 December 2020

Immunological aspects of contact sensitivity.

1 reference

12 December 2020

Functional aspects of the selective depletion of lymphoid tissue by cyclophosphamide.

1 reference

12 December 2020

Regulation of specific cell-mediated cytotoxic response against SV40-induced tumor associated antigens by depletion of suppressor T cells with cyclophosphamide in mice

1 reference

12 December 2020

Adoptive immunity to the guinea pig line 10 hepatoma and the nature of in vitro lymphoid-tumor cell interactions

1 reference

12 December 2020

The relation of immune depression and B-cell stimulation during the development of delayed hypersensitivity to soluble antigens

1 reference

12 December 2020

Regression of Established Tumors and Induction of Tumor Immunity by Intratumor Chemotherapy

1 reference

12 December 2020

Influence of cyclophosphamide on delayed hypersensitivity and acquired cellular resistance to Listeria monocytogenes in the mouse

1 reference

12 December 2020

B-cell suppression of delayed hypersensitivity reactions

1 reference

12 December 2020

Specific Acquired Immune Unresponsiveness to Contact Allergens with Cyclophosphamide in the Mouse

1 reference

12 December 2020

Systemic suppression of contact hypersensitivity in mice by psoralen plus UVA radiation (PUVA)

1 reference

12 December 2020

The value of an assessment of erythema and increase in thickness of the skin reaction for a full appreciation of the nature of delayed hypersensitivity in the guinea pig.

1 reference

12 December 2020

Importance of timing in cyclophosphamide therapy of MOPC-315 tumor-bearing mice

1 reference

12 December 2020

Augmentation of specific immune response against a syngeneic SV40-induced sarcoma in mice by depletion of suppressor T cells with cyclophosphamide

1 reference

12 December 2020

Enhancement of dinitrochlorobenzene (DNCB) contact sensitization by cyclophosphamide in the guinea pig.

1 reference

12 December 2020

Interference of anti-tumor and immunosuppressive effects of cyclophosphamide in tumor-bearing rats. Analysis of factors determining resistance or susceptibility to a subsequent tumor challenge

1 reference

12 December 2020

Direct in vitro evidence for different susceptibilities to 4-hydroperoxycyclophosphamide of antigen-primed T cells regulating humoral and cell-mediated immune responses to sheep erythrocytes: a possible explanation for the inverse action of cyclopho

1 reference

12 December 2020

Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes

1 reference

12 December 2020

Local administration of cytostatic drug 4-hydroperoxy-cyclophosphamide (4-HPCY) facilitates cell-mediated immune reactions.

1 reference

12 December 2020

Induction of tumor immunity by intratumoral chemotherapy

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00232355

1 reference

29 May 2018

1 reference

29 May 2018